PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension

Author(s):
Kwapiszewska, G.; Markart, P.; Dahal, B.K.; Kojonazarov, B.; Marsh, L.M.; Schermuly, R.T.; Taube, C. (0000-0002-3546-1398); Meinhardt, A.; Ghofrani, H.A.; Steinhoff, M.; Seeger, W.; Preissner, K.T.; Olschewski, A.; Weissmann, N.; Wygrecka, M.
Published
2012
Publication type
Article / Letter to editor
pulmonary arterial hypertensionprotease-activated receptor-2mast cells
Date issued
2012-04-27
Language
English
Is part of
Circulation Research (2012), Vol. 110, no. 9, p. 1179-+
hdl
1887/98547
doi
10.1161/CIRCRESAHA.111.257568